Zimmer Biomet
Zimmer Biomet Holdings, Inc., commonly referred to as Zimmer Biomet, is a leading global medical device company headquartered in the United States. Founded in 1927, the company has established a strong presence in the orthopaedics and musculoskeletal sectors, focusing on innovative solutions for joint reconstruction, trauma, spine, and dental applications. With major operational regions across North America, Europe, and Asia-Pacific, Zimmer Biomet is renowned for its advanced products, including joint replacement implants and surgical instruments. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the healthcare industry. Notably, Zimmer Biomet's unique offerings, such as personalised surgical solutions and cutting-edge robotic technologies, enhance patient outcomes and streamline surgical procedures, solidifying its market leadership.
DitchCarbon Score
How does Zimmer Biomet's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zimmer Biomet's score of 41 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zimmer Biomet's reported carbon emissions
In 2023, Zimmer Biomet reported total market-based greenhouse gas emissions of approximately 82,993,000 kg CO2e, comprising 10,615,000 kg CO2e from Scope 1 and 72,379,000 kg CO2e from Scope 2. This marks a significant reduction from previous years, with emissions of about 89,801,000 kg CO2e in 2022, 142,176,000 kg CO2e in 2021, and 173,568,000 kg CO2e in 2020. Zimmer Biomet has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 55% by 2030, using 2017 as the base year. Additionally, the company plans to cut absolute Scope 3 emissions from purchased goods and services by 15% by 2030, with 2019 as the reference year. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. Overall, Zimmer Biomet's proactive approach to reducing carbon emissions reflects its commitment to sustainability and environmental responsibility within the healthcare equipment and supplies sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zimmer Biomet is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
